Welcome to the Genome Stability Group pages

Our research focuses on understanding how cells maintain integrity of their genomes in the face of internal and external damage, originating e.g. during DNA replication or upon exposure to chemotherapeutic agents. We use both basic science and translational approaches, the latter concentrating on high-grade serous ovarian cancer patient samples. Our aim is to provide biological insights that will be useful in clinical decision-making, either immediately or in the longer term.
Read more
@LabKauppi

Congratulations to the Keeney (@Spo11Rulz) and Jasin labs on yet another insightful paper on pseudoautosomal region… twitter.com/i/web/status/1…

CHEMORESPONSE-hankkeessa luodaan malli, jonka avulla kullekin munasarjasyöpäpotilaalle voidaan suunnitella hänen sy… twitter.com/i/web/status/1…

This #WorldCancerDay we want to thank all cancer researchers and medical professionals. These are the people curin… twitter.com/i/web/status/1…

Congratulations to the poster winners 1. Erdogan Erkan @AnnaVaharautio lab, 2. @barunlz from @LabKauppi and 3. Osca… twitter.com/i/web/status/1…

@TERVA_OvCa

Back in Business with #ovariancancer fresh sample collection👌 in @HerculesOvCa and @TERVA_OvCa 😊 Read @turunsanomattwitter.com/i/web/status/1…

Webinar by ONCOSYS @helsinkiuni. Heini Lassus: "Treatment beyond chemotherapy in high-grade serous ovarian cancer"… twitter.com/i/web/status/1…

Maailman munasarjasyöpäivää vietetään 8.5. Käyttämällä kampanjan hästägiä #PowerfulVoice osallistut tietoisuuden le… twitter.com/i/web/status/1…

Today, on the World Ovarian Cancer Day #WOCD2020 we take a look at how the #COVID19 pandemic has affected research… twitter.com/i/web/status/1…

Recent publications

RSS Feed

No results.